Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

BACKGROUND Activation of the immune system is a normal response to antigenic stimulation, and such activation enhances the replication of human immunodeficiency virus type 1 (HIV-1). We studied the effect of immunization with a common recall antigen on viral expression in HIV-1-infected patients, on the ability to isolate virus, and on the susceptibility to HIV-1 infection of peripheral-blood mononuclear cells (PBMCs) from control subjects not infected with HIV-1. METHODS Thirteen HIV-1-infected patients and 10 uninfected adults were given a 0.5-ml booster dose of tetanus toxoid. Studies were performed to evaluate changes in the degree of plasma viremia, proviral burden, the ability to isolate HIV-1, and the susceptibility of PBMCs to acute infection in vitro. Two patients underwent sequential lymph-node biopsies for the assessment of viral burden in these tissues. RESULTS All 13 HIV-1-infected patients had transient increase in plasma viremia after immunization, and the proviral burden increased in 11. These changes did not correlate with the base-line CD4+ T-cell counts. The lymph-node tissue also had increases in the proviral burden and viral RNA after immunization. The virus was more easily isolated from PBMCs from nine of the patients after immunization than before immunization. Despite considerable variability in the results, PBMCs from 7 of the 10 normal subjects were more easily infected in vitro with HIV-1 after immunization than before immunization. CONCLUSIONS Activation of the immune system by an ongoing antigen-specific immune response to an exogenous stimulus transiently increases the expression of HIV-1 and may enhance the susceptibility of uninfected subjects to HIV-1.

[1]  D. Gor,et al.  Transient elevation of serum HIV antigen levels associated with intercurrent infection. , 1991, AIDS.

[2]  P. Earl,et al.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity , 1988, Journal of virology.

[3]  E. Werner,et al.  WHO WILL GET AIDS? , 1986, The Lancet.

[4]  A. Namazi,et al.  Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination , 1995 .

[5]  Z. Bentwich,et al.  Immune activation is a dominant factor in the pathogenesis of African AIDS. , 1995, Immunology today.

[6]  A. Fauci,et al.  The effect of cytokines and pharmacologic agents on chronic HIV infection. , 1992, AIDS research and human retroviruses.

[7]  Ashley T. Haase,et al.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.

[8]  N. Nagelkerke,et al.  Transition dynamics of HIV disease in a cohort of African prostitutes: a Markov model approach. , 1990, AIDS.

[9]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[10]  P. Fultz,et al.  Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation. , 1992, AIDS research and human retroviruses.

[11]  A. Fauci,et al.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.

[12]  Jerome A. Zack,et al.  HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.

[13]  M P Dempsey,et al.  Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.

[14]  A. Fauci,et al.  Serologic and immunologic studies in patients with AIDS in North America and Africa , 1987 .

[15]  G. Pantaleo,et al.  Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Waldmann,et al.  Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. , 1985, The New England journal of medicine.

[17]  P. D. Smith,et al.  Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG. , 1991, Journal of immunology.

[18]  G. Tudor-Williams Early diagnosis of vertically acquired HIV-1 infection. , 1991, AIDS.

[19]  Anthony S. Fauci,et al.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.

[20]  R. Cheynier,et al.  Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. , 1986, Science.

[21]  T. Elbeik,et al.  Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.

[22]  A. Fauci,et al.  Induction of expression of HIV in latently or chronically infected cells. , 1989, AIDS research and human retroviruses.

[23]  K. Sell,et al.  Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. , 1986, Journal of immunology.

[24]  D. Ho HIV-1 viraemia and influenza , 1992, The Lancet.

[25]  C. Fox,et al.  Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse , 1993, The Journal of experimental medicine.

[26]  R. Virmani,et al.  Systemic lymphadenopathic histology in human immunodeficiency virus-1-seropositive drug addicts without apparent acquired immunodeficiency syndrome. , 1994, Human pathology.

[27]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[28]  M. Giacca,et al.  Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction , 1992, Journal of clinical microbiology.

[29]  P. Fultz,et al.  Immune activation and viral burden in acute disease induced by simian immunodeficiency virus SIVsmmPBj14: correlation between in vitro and in vivo events , 1994, Journal of virology.